Related Experiment Video
Updated: Aug 12, 2026
Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Published on: September 11, 2012
The effect of sulindac on colon polyps: circumvention of a transformed phenotype--a hypothesis
1Department of Surgery, University of Colorado, Denver.
Abstract:
Sulindac suppresses the growth of colon polyps in Gardner syndrome and familial adenomatous polyposis. The mechanism of action is not known. The problems are to ascertain the significance of high prostaglandin concentrations in transformed cells, colon polyps and cancers and to explain how sulindac restores normal growth patterns. A few clinical observations and an abundance of experimental data can be integrated to produce a reasonable model based on current biochemical and physiologic concepts. A fundamental defect in the formation of colon polyps is mutation of the APC (adenomatous polyposis coli) gene that leads to inadequate suppression of proliferation. There is high PGE2 content in colon polyps and cancers, presumably the result of stimulation by protein kinase C (PKC). In small quantities it stimulates cyclic AMP production but with persistent high concentrations it desensitizes and down-regulates specific PG receptors and inactivates adenylate cyclase, cAMP synthesis, and the cAMP-dependent mechanism for control of proliferation. The PKC pathway is thereby unopposed. It is hypothesized that restriction of PG synthesis by sulindac is accompanied by resensitization of PG receptors, and reactivation of the cAMP-dependent pathway for control of cell growth. It is further postulated that restoration of cAMP synthesis and protein kinase A activity converts a functionally inadequate mutant APC suppressor gene to one sufficient to inhibit colon polyp formation.
Insights
Sulindac may inhibit colon polyp growth by restoring normal cell proliferation. This involves regulating prostaglandin E2 (PGE2) and cyclic AMP (cAMP) pathways, potentially counteracting defective adenomatous polyposis coli (APC) gene function.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Colon polyps in Gardner syndrome and familial adenomatous polyposis (FAP) are linked to adenomatous polyposis coli (APC) gene mutations.
- Elevated prostaglandin E2 (PGE2) levels are observed in colon polyps and cancers, potentially driven by protein kinase C (PKC).
- Persistent high PGE2 can desensitize prostaglandin receptors, disrupt cyclic AMP (cAMP) signaling, and impair cell proliferation control, leaving the PKC pathway dominant.
Purpose of the Study:
- To investigate the role of high prostaglandin concentrations in colon polyp and cancer development.
- To elucidate the mechanism by which sulindac restores normal colon cell growth patterns.
- To propose a model integrating biochemical and physiological concepts of polyp formation and sulindac's action.
Main Methods:
- Integration of clinical observations and experimental data.
- Biochemical and physiological modeling.
- Hypothesizing sulindac's mechanism of action on prostaglandin synthesis and signaling pathways.
Main Results:
- Sulindac is known to suppress colon polyp growth in specific genetic conditions.
- A proposed model suggests sulindac restricts prostaglandin synthesis.
- This restriction may lead to resensitization of prostaglandin receptors and reactivation of cAMP-dependent proliferation control.
Conclusions:
- Sulindac's action may involve restoring prostaglandin receptor sensitivity and cAMP signaling.
- Reactivation of the cAMP pathway could convert a functionally deficient mutant APC gene into one capable of inhibiting polyp formation.
- This mechanism offers a potential explanation for sulindac's efficacy in suppressing colon polyps.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
06:24Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
